# Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)

> **NCT04395846** · — · ACTIVE_NOT_RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 350 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04395846
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-02
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395846, "Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04395846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
